Form 8-K - Current report:
SEC Accession No. 0001181431-14-016305
Filing Date
2014-04-16
Accepted
2014-04-16 16:30:04
Documents
2
Period of Report
2014-04-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd407491.htm 8-K 12607
2 DYNAVAX INITIATES PHASE 3 STUDY OF HEPLISAV-B(TM). rrd407491_40618.htm EX-99 6510
  Complete submission text file 0001181431-14-016305.txt   20218
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 14767802
SIC: 2834 Pharmaceutical Preparations